[Bio-software] New Targets and Drug Modalities

James Prudhomme via bio-soft%40net.bio.net (by jprudhomme from healthtech.com)
Tue Apr 19 13:23:30 EST 2011


CHI and Bio-IT World's "Structure-Based Design" Conference to be held on
June 8-10, 2011 in Cambridge, MA, will 
feature a new session:  New Targets and Drug Modalities.

The following presentations have just been added and are scheduled on
Friday, June 10 from 1:30-3:50 p.m.

Structure-Based Ligand Discovery for GPCRs
Ruben Abagyan, Ph.D., Professor, Skaggs School of Pharmacy and
Pharmaceutical Sciences, University of California,
San Diego

The Role of Recent Crystal Structures of Membrane Bound Proteins in Drug
Discovery for CNS Targets
Sid Topiol, Ph.D., CSO, Computational and Structural Investigations,
3D-2Drug

Hitting a Moving Target: Characterizing GPCR Signaling through
Long-timescale Molecular Dynamics Simulations
Ron Dror, Ph.D., Senior Research Scientist and Special Advisor to the
Chairman, D. E. Shaw Research

Beyond the Orthosteric Binding Site: A Structure-Based SAR Analysis of the
D3R Selective Compounds
Lei Shi, Ph.D., Assistant Professor, Department of Physiology and
Biophysics, HRH Prince Alwaleed Bin Talal Bin 
Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell
Medical College

Moving in New Circles - Exploiting Macrocycles for Drug Discovery
Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.

View full details and register at: http://www.healthtech.com/sbd or call
781-972-5400.

Those that register by April 29 will receive the advanced registration
discount. 

***

James Prudhomme
Marketing Manager
Cambridge Healthtech Institute
250 First Avenue, Suite 300
Needham, MA 02494
Tel: 781-972-5486
Fax: 781-972-5425
www.healthtech.com

 

 



More information about the Bio-soft mailing list